跳至主要内容
临床试验/NCT01091155
NCT01091155已完成4 期

COMPRES - COMpression Anastomosis Ring (CAR™ 27/ColonRing™) Post maRketing Evaluation Study

novoGI20 个研究点 分布在 6 个国家目标入组 288 人开始时间: 2010年3月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
288
试验地点
20
主要终点
To Evaluate Rate of Anastomotic Leaks Related to the Use of the ColonRing™ Device, at 1 Month

研究概览

简要总结

The performance of the ColonRing™ will be comparable to or better than the reported performance of staplers.

详细描述

The proposed study is a post marketing study intended to gather and record additional data to further evaluate the performance of the ColonRing™ device in regards to the creation of a colorectal anastomosis.

The study objective is to evaluate the performance of the ColonRing™ in the creation of a circular anastomosis in colorectal procedures.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is ≥ 18 years old.
  • Subject is planned to undergo a non-emergency (i.e., elective) operation with the creation of an anastomosis using the ColonRing™.
  • Subject signs and dates a written informed consent form (ICF) and indicates an understanding of the study procedures.

排除标准

  • Subject has a known allergy to nickel.
  • Subject is planned to undergo an emergency procedure or has a diagnosis of bowel strangulation, peritonitis, bowel perforation, local or systemic infection, ischemic bowel,carcinomatosis.
  • Subject has participated in another clinical study which may affect this study's outcomes within the last 30 days.
  • Subject's ASA (American Society of Anesthesiology) score 4 or
  • Subject has a concurrent or previous invasive pelvic malignancy.
  • Subject has a systemic or incapacitating disease.
  • Subject has extensive local disease in the pelvis.
  • Subject requires more than one anastomosis during the surgery.
  • Women who are known to be pregnant.

结局指标

主要结局

To Evaluate Rate of Anastomotic Leaks Related to the Use of the ColonRing™ Device, at 1 Month

时间窗: Approx. 1 year

Anastomotic leakage will be defined as clinical symptoms such as fever or sepsis in combination with pelvic abscess, rectovaginal fistula or peritonitis within 30 days postoperatively leading to a clinical and / or radiological interventional procedure of the subject, or operation that confirms the leakage which has been determined to be related to the device.

Device Related Leak Rate up to 30 Days Post op

时间窗: 30 days post op

Anastomotic leakage will be defined as clinical symptoms such as fever or sepsis in combination with pelvic abscess, rectovaginal fistula or peritonitis within 30 days postoperatively leading to a clinical and / or radiological interventional procedure of the subject, or operation that confirms the leakage which has been determined to be related to the device.

次要结局

  • Rate of Other Device Related Complications and Other Parameters During Hospitalization and Post Procedure.(30 days post op)

研究者

发起方
novoGI
申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验